ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000246250.2	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.033158091	Sensitive
ENSG00000246250.2	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.00217672	Sensitive